$12B biotech Biosplice lays off 41, axes hair loss asset
09 Feb 2022 //
FIERCEBIOTECH
Samumed Announces Publication of Phase 2 Data on Lorecivivint
22 May 2020 //
YAHOO
In conversation with Osman Kibar, CEO of Samumed
15 Aug 2019 //
FIERCE BIOTECH
Samumed & United Therapeutics Announce License Agreement For IPF Drug Candidate
17 Sep 2018 //
PR NEWSWIRE
Samumed, a $12 billion startup, just raised more funding as it plots an IPO
07 Aug 2018 //
BUSINESS INSIDER